snuh-cd19-car-t
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 15, 2022 (NCT05210907)
Timeline
Indications
Mechanism of action
- B-lymphocyte antigen CD19BINDING AGENT
CD19
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06247501 | Phase 2 | Jan 19, 2024 | Seoul National University |
| NCT05210907 | Phase 1 | Feb 15, 2022 | Seoul National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seoul National University | Academic/Hospital | 2 | 2 | 2 | 2022 |
1 organizations
Page 1 / 1